Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies.

  • Authors : Lu X; Laboratory of Molecular Immunology, Immunology Frontier Research Center, Osaka University, Suita, Japan.; Hayashi H

Subjects: Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood ; Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/immunology

  • Source: ELife [Elife] 2024 May 08; Vol. 12. Date of Electronic Publication: 2024 May 08.Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Follow-Up and Comparative Assessment of SARS-CoV-2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA-1273 Heterologous Booster Vaccination.

  • Authors : Younes S; Biomedical Sciences Department, College of Health Sciences, Qatar University, Doha, Qatar.; Biomedical Research Center, Qatar University, Doha, Qatar.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/blood

  • Source: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 May; Vol. 18 (5), pp. e13290.Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print Cited Medium: Internet ISSN: 1750-2659 (Electronic)

Record details

×
Editorial & Opinion

Immunogenicity of BNT162b2 vaccine after two and three doses: Correspondence.

  • Authors : Daungsupawong H; Private Academic Consultant, Phonhong, Lao Democratic People's Republic. Electronic address: .; Wiwanitkit V

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage

  • Source: Semergen [Semergen] 2024 May-Jun; Vol. 50 (4), pp. 102132. Date of Electronic Publication: 2024 Jan 30.Publisher: Saned, S.A Country of Publication: Spain NLM ID: 9610769 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-8865

Record details

×
Academic Journal

Third vaccine boosters and anti-S-IgG levels: A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinoma.

  • Authors : Wang CW; Division of Hepatobiliary, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/immunology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/immunology ; Immunoglobulin G*/Immunoglobulin G*/Immunoglobulin G*/blood

  • Source: The Kaohsiung journal of medical sciences [Kaohsiung J Med Sci] 2024 May; Vol. 40 (5), pp. 477-488. Date of Electronic Publication: 2024 Feb 16.Publisher: Department of Public Health, Kaohsiung Medical University Country of Publication: China (Republic : 1949- ) NLM ID: 100960562 Publication Model:

Record details

×
Academic Journal

Effectiveness of mRNA COVID-19 Vaccines as First Booster Doses in England: An Observational Study in OpenSAFELY-TPP.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Immunization, Secondary* ; BNT162 Vaccine*

  • Source: Epidemiology (Cambridge, Mass.) [Epidemiology] 2024 Jul 01; Vol. 35 (4), pp. 568-578. Date of Electronic Publication: 2024 Jun 24.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9009644 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

B and T cell responses to the BNT162b2 COVID-19 mRNA vaccine are not impaired in germ-free or antibiotic-treated mice.

  • Authors : Norton T; Precision Medicine, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.; Lynn MA

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology

  • Source: Gut [Gut] 2024 Jun 06; Vol. 73 (7), pp. 1222-1224. Date of Electronic Publication: 2024 Jun 06.Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

How effective is the BNT162b2 mRNA vaccine against SARS-CoV-2 transmission and infection? A national programme analysis in Monaco, July 2021 to September 2022.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology SARS-CoV-2 variants

  • Source: BMC medicine [BMC Med] 2024 Jun 05; Vol. 22 (1), pp. 227. Date of Electronic Publication: 2024 Jun 05.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015

Record details

×
Academic Journal

Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection by Type and Frequency of Vaccine: A Community-Based Case-Control Study.

  • Authors : Gim H; Infectious Disease Research Center, Citizens' Health Bureau, Seoul Metropolitan Government, Seoul, Korea.; Seo H

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/epidemiology

  • Source: Journal of Korean medical science [J Korean Med Sci] 2024 Jun 03; Vol. 39 (21), pp. e174. Date of Electronic Publication: 2024 Jun 03.Publisher: Korean Academy of Medical Science Country of Publication: Korea (South) NLM ID: 8703518 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccination.

  • Authors : Khalid MB; Food Allergy Research Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.; Zektser E

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; BNT162 Vaccine*

  • Source: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2024 Jun; Vol. 153 (6), pp. 1634-1646. Date of Electronic Publication: 2024 Mar 07.Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825

Record details

×
Academic Journal

COVID-19 Vaccine-Associated Uveitis in Patients With a History of Uveitis.

  • Authors : Kim J; Department of Pre-Medicine, College of Medicine, and Biostatistics Lab, Medical Research Collaborating Center, Hanyang University, Seoul, Korea.; Kwon HY

Subjects: Uveitis*/Uveitis*/Uveitis*/etiology ; Uveitis*/Uveitis*/Uveitis*/diagnosis ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: JAMA ophthalmology [JAMA Ophthalmol] 2024 Jun 01; Vol. 142 (6), pp. 522-528.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×